DO WE HAVE TO SCREEN PATIENTS WITH ADRENAL INCIDENTALOMA FOR PRIMARY ALDOSTERONISM? von Stavropoulos, K, Imprialos, K, Petidis, K, Kamparoudis, A, Petras, P, Zografou, I, Katsiki, N, Kerpiniotis, G, Manafis, A, Bouloukou, S, Lales, G, Mitas, C, Georgopoulou, V, Athyros, V, Karagiannis, A, Doumas, M

Volltext

FEMALE SEXUAL DYSFUNCTION WITH DIURETICS IN WOMEN WITH ARTERIAL HYPERTENSION von Stavropoulos, K., Imprialos, K., Petidis, K., Kerpiniotis, G., Mitas, C., Katsiki, N., Patoulias, D., Sachinidis, A., Dimitriadis, K., Tsioufis, K., Grassos, H., Pittaras, A., Manolis, A.J., Lovic, D., Athyros, V., Karagiannis, A., Doumas, M.

Volltext

A PREGNANT WOMAN WITH PSEUDOHYPERALDOSTERONISM DUE TO MUMIJO CONSUMPTION: A LICORICE-LIKE SYNDROME von Imprialos, K., Stavropoulos, K., Patoulias, D., Bouloukou, S., Kerpiniotis, G., Lales, G., Manafis, A., Mitas, C., Petidis, K., Athyros, V., Karagiannis, A., Doumas, M.

Volltext

Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling von Chen, Li, Shi, Rui, She, Xia, Gu, Chaochao, Chong, Li, Zhang, Lina, Li, Rui

Volltext

Role of spironolactone in patients with resistant hypertension: A narrative review von Sheth, Geeta, Joshi, Kavita

Volltext